Kidney and urinary system
Kidney Claims in India: What India Claims and Screening Data Shows
Section titled “Kidney Claims in India: What India Claims and Screening Data Shows”- Of all hospitalizations are kidney and urinary
- 5%
- Average cost per claim
- ₹52,351
- Total insurance spend
- ₹21.14 Cr
- Of screened employees have abnormal or borderline kidney results
- 56.2%
A 38-year-old employee in Bangalore has not drunk water since his morning coffee. He is in back-to-back meetings. By mid-afternoon he feels a dull ache in his lower back. He takes a painkiller and pushes through. Two days later, the pain becomes unbearable. He is admitted to hospital with a 6mm kidney stone. He is discharged in two days. He assumes it was a one-time event.
It was not. Kidney stone formers have a 50% chance of recurrence within five years. Each episode causes incremental renal damage. Over a decade, the employee who dismissed his stone as a one-time inconvenience is on a pathway toward chronic kidney disease; the same condition his father is already being hospitalised for.
This is the defining story of the kidney chapter: a slow, generational pipeline where today’s employee lifestyle conditions become tomorrow’s parent chronic disease claims, and today’s parent chronic disease previews what the employee will face in twenty years.
Kidney and urinary disorders account for 5% of all hospitalizations, making this one of the more concentrated cost chapters in our data. Average cost per claim: ₹52,351. Total insurance spend: ₹21.14 crore.
This mirrors a national pattern. A 2025 systematic review of Indian chronic kidney disease studies found that the prevalence rose from 11.1% during 2011 to 2017 to 16.4% between 2018 and 2023. The SEEK-India study, screening more than 5,500 individuals across 13 medical centers, reported an overall prevalence of chronic kidney disease (CKD) of 17.2%, with approximately 6% at stage 3 or worse.
Which kidney conditions do employees and their parents get?
Section titled “Which kidney conditions do employees and their parents get?”Who files the most kidney claims: employees, parents, spouses, or children
Section titled “Who files the most kidney claims: employees, parents, spouses, or children”Among kidney claims tracked at the relationship level, a clear pattern emerges. Parents account for nearly half of all claims and are hospitalised at four times the employee rate. But spouses, at 11%, are a meaningful part of this chapter and should not be ignored.
| Who | % of claims | Hospitalised per 1,000 enrolled per year (FY2025) | Average cost per claim | What it means |
|---|---|---|---|---|
| Parents | 49% | 6.4 (highest) | ₹51,932 | Predominantly CKD. Chronic, recurring, escalating toward dialysis. |
| Employee (self) | 35.70% | 1.9 | ₹53,261 | Predominantly kidney stones. Acute, preventable, recurring risk. |
| Spouse | 11.10% | 1.8 | ₹51,202 | Mix of stones and urinary infections. Not negligible. |
| Child | 3.70% | 0.6 | ₹43,566 | Mostly UTIs. Manageable with OPD access. |
These are not two versions of the same problem. They are two distinct diseases on the same plan, requiring entirely different responses. Parents are hospitalised primarily for chronic kidney disease: organ deterioration from decades of unmanaged blood pressure, diabetes and dehydration. Employees show up primarily for kidney stones: a dehydration and lifestyle condition hitting working-age adults that is both acute and preventable.
AIIMS research in first-degree relatives of CKD patients found a CKD prevalence of 9.9%, with hypertension in 31% and impaired fasting glucose in 22%; yet awareness was extremely low even among families already affected by kidney failure. Our data confirms this: parents are filing the claims, but the metabolic drivers are already visible in employee screening results.
What is the largest kidney claim category in group health insurance?
Section titled “What is the largest kidney claim category in group health insurance?”Chronic kidney disease and acute kidney failure account for 41.6% of all kidney claims, making CKD the dominant sub-condition in kidney-related claims.
This matters because CKD is irreversible, recurring and escalates over time toward dialysis. Kidney stones, at 35.7%, are close behind but represent a more acute, more preventable and, critically, a potentially reversible condition if addressed early.
| Sub-condition | % of chapter | Average cost | What it means |
|---|---|---|---|
| Acute kidney failure and chronic kidney disease | 41.6% (largest) | ₹42,089 | Predominantly parents. Irreversible once progressed. |
| Urolithiasis (kidney stones) | 36% | ₹60,478 | Primarily employees. Preventable. Costlier per case than CKD. |
| Other diseases of the urinary system | 17% | ₹57,850 | UTIs, bladder conditions; often female, often recurring. |
| Tubulo-interstitial diseases | 5% | ₹59,587 | Drug-induced or infection-driven kidney inflammation. Often missed. |
| Glomerular diseases | 0.8% | ₹62,739 | Low volume, high cost. Complex autoimmune kidney conditions. |
Kidney stones cost more per claim at ₹60,478 than CKD at ₹42,089. This seems counterintuitive: stones feel more acute, CKD feels more serious. The explanation is that most CKD admissions in this dataset are earlier-stage management episodes, while stone events involve surgical intervention (ureteroscopy, lithotripsy) that drives higher procedure costs. But CKD’s true cost advantage disappears entirely once patients progress to regular dialysis, at which point utilisation becomes continuous rather than episodic.
Research estimates that approximately 8 to 10% of workers who experience acute kidney injury go on to develop CKD within 12 months, with one acute kidney injury increasing the risk of developing CKD five-fold within five years. The stones-to-chronic pipeline is precisely what the data shows accelerating.
Which Indian cities have the highest kidney abnormality rates?
Section titled “Which Indian cities have the highest kidney abnormality rates?”The city breakdown reveals two distinct patterns. Mumbai and Chennai show a female-dominant abnormality profile, consistent with the UTI-to-kidney pipeline. Delhi, Bangalore, Hyderabad and Gurgaon show a male-dominant pattern, consistent with stone disease and uric acid elevation driven by dehydration and high-protein diets.
| City | Abnormality rate | M:F ratio (abnormal) | Pattern | What it means |
|---|---|---|---|---|
| Gurgaon | 35.8% (highest) | 1.83 | Men lead strongly | Corporate belt: long hours, meetings, low water intake. |
| Kanpur | 33.7% | n/a | n/a | Water quality risk compounding chronic dehydration. |
| New Delhi | 27.6% | 1.4 | Men lead | High heat, long commutes, stone-pattern risk. |
| Chennai | 25.3% | 0.83 | Women lead | UTI-to-kidney pipeline. Women disproportionately affected. |
| Bangalore | 25% | 1.2 | Men lead | Largest screened cohort. Stone and uric acid pattern. |
| Mumbai | 22.4% | 0.88 | Women lead | Consistent UTI pipeline: women outnumbering men in abnormals. |
| Hyderabad | 20.8% | 1.16 | Men lead | Stone-pattern risk, male-dominant. |
Gurgaon at 35.8% is the highest abnormality rate of any city, reflecting the corporate belt profile of long indoor hours, back-to-back meetings and a work culture where taking a water break feels like an interruption. Kanpur adds a water quality dimension, where environmental contamination compounds the dehydration picture. Mumbai and Chennai’s female-dominant pattern calls for a different response: OPD access for urological care and UTI management, not hydration campaigns.
Nationally, urine problems skew 2.7x in females, the sharpest gender gap in any health check-up test. The kidney screening profile is also the most evenly spread across age groups (42% in 20 to 30, 18% in 31 to 35, 8% in 36 to 40, 32% in 41+), meaning this is not just an aging problem; it is building at every stage.
Employees today showing kidney abnormalities are on the same trajectory their parents are now claiming for. The 10-year lag between a screening red flag and a hospitalization claim is playing out in real time.
The SEEK-India study stressed that early intervention may slow disease progression and called for preventive health policies and greater resource allocation for CKD patients. AIIMS and ICMR have emphasized that in India, where CKD screening programs are still nascent, targeting high-risk individuals represents the most practical first step. Our health check-up data shows kidneys already flagged, representing exactly the early detection opportunity these institutions are calling for.
Do men or women have more kidney problems?
Section titled “Do men or women have more kidney problems?”In claims data, men account for 62.7% of kidney hospitalizations at 2.89 per 1,000, compared to 37.3% for women at 2.19 per 1,000. This male dominance is driven by kidney stones, which have a well-established male prevalence due to higher protein intake, greater dehydration risk in physical and field roles and hormonal factors.
But in health check-up data, the picture reverses. Of the total employees screened for kidney function markers, women showed abnormal or borderline results at a higher rate than men: 26.3% versus 22.2%. Women are less likely to reach the hospital for kidney conditions, but they are more likely to have subclinical abnormalities going unaddressed. This gap is explained by urinary tract infections, which show up as kidney marker derangements in screening but are often managed, or not managed, at OPD level rather than escalating to hospital. Recurrent UTIs that are undertreated progress to kidney infections and tubulo-interstitial disease, a category growing at 11.2x in our claims data.
| Gender | % of kidney claims | Incidence (per 1,000) | Screening abnormality rate |
|---|---|---|---|
| Male | 63% | 2.89 | 22.2% of men screened |
| Female | 37% | 2.19 | 26.3% of women screened (higher) |
What do health check-ups reveal about future kidney claims?
Section titled “What do health check-ups reveal about future kidney claims?”Of all the employees screened for kidney function markers, 56.2% showed abnormal or borderline results. This is the condition where the screening-to-claims pipeline is most visible. More than half of screened employees have measurable kidney stress that has not yet converted to a hospitalization claim.
Employees with an abnormal or borderline kidney marker
- Abnormal or borderline
- Highlighted
View as table
| Category | Abnormal or borderline |
|---|---|
| BUN / creatinine ratio | 79.1% |
| Blood urea | 25.1% |
| BUN | 20% |
| Serum uric acid | 16.1% |
| Creatinine | 10.4% |
| eGFR (kidney filtration rate) | 8.2% |
- BUN / creatinine ratio: a dehydration and kidney stress marker; 4 in 5 results are abnormal.
- Blood urea: elevated urea means the kidneys are struggling to filter waste.
- BUN (blood urea nitrogen): consistent with the blood urea signal.
- Serum uric acid: elevated uric acid is a direct precursor to kidney stones and gout.
- Creatinine: the gold-standard kidney filter marker; 1 in 10 already elevated.
- eGFR: a direct measure of kidney function decline; already below normal in 8.2%.
The BUN/creatinine ratio at 79.1% abnormality is the most urgent finding: four in five employees tested are showing chronic dehydration at the kidney level, the direct upstream driver of kidney stones.
Elevated serum uric acid at 16.1% is a direct precursor to stones and gout. Elevated creatinine at 10.4% and eGFR below normal at 8.2% mean kidney filtration is already compromised in a measurable share of the screened workforce. These employees are on a CKD trajectory years before they generate a hospitalization claim.
The screening profile is also strikingly uniform across age groups: abnormality rates are 24.0% in the 20 to 30 band, 22.2% in the 31 to 35 band, 21.3% in the 36 to 40 band and 26.1% above 41. This is not just an aging problem. It is being built at every stage of the workforce.
How do kidney claims affect employers and insurance renewals?
Section titled “How do kidney claims affect employers and insurance renewals?”Kidney-related claims carry a unique organizational burden:
- They often lead to repeat hospitalizations.
- Recovery periods are long and uncertain.
- Employees supporting affected parents experience sustained caregiving stress.
- Insurers view recurring kidney claims as high-risk signals during renewals.
Even though kidney claims form 5.22% of total admissions, their cumulative cost impact is disproportionately high over time. A single chronic kidney disease patient can generate claims across multiple quarters, and once dialysis begins, utilization rarely stops.
While some admissions appear acute, the data suggests many are late presentations of underlying metabolic dysfunction rather than isolated events. Kidney claims frequently co-exist with cardiac conditions, diabetes and hypertension. This reinforces kidney disease as a downstream organ failure, not a primary condition.
What early signs of kidney disease can employers spot in health check-ups?
Section titled “What early signs of kidney disease can employers spot in health check-ups?”The kidney system is particularly sensitive to poor glycemic control, long-standing hypertension, dehydration and medication overuse. Preventive screenings often detect early abnormalities in creatinine or urine markers, but follow-up adherence is inconsistent. When early signals are ignored, hospitalization becomes the point of discovery.
How can HR reduce kidney claims?
Section titled “How can HR reduce kidney claims?”Kidney and urinary disorders represent one of the clearest cases where early detection changes everything. Once kidney disease reaches the point of hospitalization, utilization rarely remains a one-time event.
Preventive actions
Section titled “Preventive actions”- Flag abnormal results and follow up. Flag employees with abnormal creatinine, urine protein, or eGFR in annual health check-ups and ensure structured follow-up, not just report delivery.
- Prioritize hydration awareness, especially during summer months, particularly for employees with existing kidney markers and for parents covered under the plan. Our data shows a 3.4x parent kidney spike in summer, so pre-summer health advisories could reduce preventable admissions.
- Address the upstream drivers. Unmanaged diabetes and hypertension are the two most common feeders into chronic kidney disease.
- Track repeat kidney claims separately in renewal discussions; they distort loss ratios more than their volume suggests.
Policy and coverage actions
Section titled “Policy and coverage actions”- Ensure dialysis and nephrology OPD consultations are covered under outpatient benefits. Catching kidney decline early is far cheaper than repeated inpatient episodes.
- Consider separate tracking of parent kidney claims in utilization reviews, given they represent 63.7% of the kidney burden and carry the highest per-claim cost.
- Align coverage with the seasonal reality. Since kidney claims run 2.4x higher in April, May and June, pre-summer health advisories for aging dependents could meaningfully reduce preventable admissions.
Kidney claims remind us that not all risks arrive loudly. Some arrive quietly, stay permanently and compound steadily.
Sources
Section titled “Sources”- Pazcare claims and health check-up data, as described in Methods and data sources.
- SEEK-India study (BMC Nephrology), as cited in the PDF.
- AIIMS and ICMR research (Karger, Nephron Clinical Practice), as cited in the PDF.
- A 2025 systematic review of chronic kidney disease studies in India, as cited in the PDF. The PDF gives no links for these.